335349-58-1Relevant articles and documents
KINASE INHIBITORS AND METHODS OF SYNTHESIS AND TREATMENT
-
Paragraph 0166-0168, (2021/03/05)
Compounds that function as kinase inhibitors are provided. The kinase inhibitors can have any structure of the formulae provided herein, such as shown for Compounds 1-4. A pharmaceutical composition can include: the compound of one of the embodiments; and
Glutamate receptor antagonists
-
, (2008/06/13)
The present invention relates to compounds of with a base structure of formula 1 The compounds of formula I are shown to have activity as metabotropic glutamate receptor antagonists.